The 12 closest competitors and alternatives to Abalone Bio among biotechnology companies — ranked by similarity to what Abalone Bio actually does, not by market-cap band.
Subscribe to see Abalone Bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Abalone Bio is a preclinical-stage biotechnology company headquartered in Emeryville, California, that develops therapeutic antibody drugs targeting GPCRs, ion channels, and other membrane proteins.
Abalone Bio is a biotechnology company headquartered in United States. It has raised at least $150,000 across the 2 funding rounds on record, 1 of them with a disclosed amount. Its most recent funding round, Grant, closed in June 2020. Xcout tracks 9 named people at Abalone Bio, including Toshi Takeuchi (CSO).
3 more named people on record for Abalone Bio, with roles, board committees and tenure — see the full roster →
At least $150,000 raised across the 2 rounds on record (1 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Grant | Undisclosed | 1 named | |
| Seed | $150,000 | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Abalone Bio by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Prellis Biologics, Inc. is a privately held biotechnology company headquartered in Berkeley, California, within the San Francisco Bay Area. It develops human antibody therapeutics and focuses on antibody discovery leveraging AI and immune diversity.
Similar biotechnology company
Great Bay Bio is a biotech company headquartered in HKSTP that drives drug development using cutting-edge technologies such as AI and big data mining.
Similar biotechnology company
Standard Model Biomedicine is a biotechnology research company based in San Francisco, United States. The company is focused on developing a foundation model for human biology to advance biomedical research.
Biotech
Archon Biosciences is a biotechnology company based in Seattle, Washington, supported by investors like Madrona Ventures. The company utilizes its proprietary AbC technology platform to develop innovative therapeutics and advance drug pipelines.
Similar biotechnology company
Adnexus Biotechnologies is a drug discovery and biotechnology company headquartered in Texas that focuses on delivering accessible and affordable therapeutic solutions.
Biotech
NeuroX1 Inc. is a for-profit biotechnology startup founded in 2021 with headquarters in Austin, Texas, operating a target identification and drug discovery platform that utilizes proprietary technology.
Similar biotechnology company
Avicenna Biosciences, Inc. is a biotechnology company that uses machine learning-enhanced medicinal chemistry to accelerate drug discovery and optimization.
Biotech
OmniAb, Inc. is an American biotechnology firm focused on pioneering therapeutic antibody discovery. The company provides a sophisticated platform that allows its industry partners to access a broad spectrum of antibody repertoires and advanced screening techniques, thereby facilitating the development of next-generation treatments. Central to the OmniAb platform is the unique biological capability of proprietary genetically engineered animals, such as OmniRat, OmniChicken, and OmniMouse. These animals are modified to produce human-sequence antibodies, simplifying the creation of human therapeutic candidates. Additionally, OmniAb offers specialized technologies like OmniFlic (a transgenic rat) and OmniClic (a transgenic chicken), which address the requirements for bispecific antibody applications via a common light chain method, as well as OmniTaur, which leverages the distinct structural properties of cow antibodies for challenging targets. The company was founded in 2012 and is based in Emeryville, California.
Biotech
AbCellera is a biotechnology company that integrates biology, computation, and engineering to discover and develop antibody-based medicines. The company operates a proprietary technology platform to advance internal and partnered drug programs across therapeutic areas such as endocrinology, immunology, autoimmunity, and oncology.
Biotech
Infinimmune is an Alameda, California-based biotechnology company founded in 2022 that develops human-derived antibody medicines and holds a massive database of paired heavy and light sequences.
Biotech
Abilita Therapeutics, Inc. is a privately held biotechnology company founded in 2014 and focused on redefining therapeutics. The company is headquartered in San Diego, California.
Similar biotechnology company
Ablytx is a biotechnology company headquartered in San Diego and Del Mar, California. The company pioneers a class of medicines designed to selectively remove disease-driving proteins from cell surfaces.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Abalone Bioand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →